OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
October 08, 2024
According to the annual survey, four of the five biggest biologics capacity holders in 2028 will comprise CMOs, which are expected to have 45% of all CMO capacity in Asia.
October 07, 2024
The nanofiber microcarriers are the first of their kind for manufacturing viral vectors used in gene therapy production, according to Cellevate.
October 02, 2024
Contract organizations offer assistance for testing raw materials obtained from outside suppliers.
As part of a range of sustainable products and services that SGD Pharma plans to showcase at CPHI Milan, the company will introduce its siliconized molded glass vials.
September 27, 2024
According to the survey results, 49% of industry respondents are “highly positive” on the contract services sector seeing growth over the next 18 months.
September 25, 2024
Lonza signed a long-term supply agreement to manufacture CASGEVY (exagamglogene autotemcel) for Vertex at its facility in Geleen, the Netherlands, and plans to expand manufacturing to Portsmouth, NH, in the United States.
September 24, 2024
Contract organizations offer assistance when managing changes to material suppliers during a product’s lifecycle.
September 05, 2024
Qualifying material suppliers is a crucial step in ensuring safe and effective drug products.
Rentschler Biopharma has expanded its service offerings at its Stevenage, UK, site with a new lentiviral vector manufacturing toolbox.
August 22, 2024
Vernal Biosciences’ CEO and founder, Christian Cobaugh, discusses the outsourcing landscape for mRNA production.